Global Castrate-resistant Prostate Cancer Databank Market Report

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,000	100 Pages	Magna Intelligence	April, 2024	MAIN18749863

Best Price Guarantee
Price	from $2,000
Length	100 Pages
Publisher	Magna Intelligence
Published Date	April, 2024
SKU	MAIN18749863

Global Castrate-resistant Prostate Cancer Databank Market Report

The Castrate-resistant Prostate Cancer market was valued at $8,721.3 Million in 2022, and is projected to reach $15,584.9 Million by 2031 growing at a CAGR of 6.71% from 2023 to 2031. Hormonal Therapy segment is expected to be the highest contributor to this market, with $7,227.4 Million in 2022, and is anticipated to reach $12,564.7 Million by 2031, registering a CAGR of 6.39%. Chemotherapy segment is anticipated to reach $1,192.5 Million by 2031 with the highest CAGR of 8.53%. Hormonal Therapy and Immunotherapy segments collectively expected to account for about 91.4% share of the Castrate-resistant Prostate Cancer market in 2022, with the former constituting around 82.9% share. Chemotherapy and Radiotherapy segments are expected to witness significant growth rates at a CAGR of 8.53% and 8.37% respectively, during the forecast period. Presently, share of these two segments is estimated to be around 8.6% in the overall Castrate-resistant Prostate Cancer market in 2022, and is anticipated to reach 9.9% by 2031.

1. Global Castrate-resistant Prostate Cancer Market, By Therapy: 1.1. Overview; 1.2. Chemotherapy; 1.2.1 Chemotherapy Market, By Region; 1.2.1.1 North America Chemotherapy Market, By Country; 1.2.1.2 Europe Chemotherapy Market, By Country; 1.2.1.3 Asia-Pacific Chemotherapy Market, By Country; 1.2.1.4 Rest of World Chemotherapy Market, By Country; 1.3. Hormonal Therapy; 1.3.1 Hormonal Therapy Market, By Region; 1.3.1.1 North America Hormonal Therapy Market, By Country; 1.3.1.2 Europe Hormonal Therapy Market, By Country; 1.3.1.3 Asia-Pacific Hormonal Therapy Market, By Country; 1.3.1.4 Rest of World Hormonal Therapy Market, By Country; 1.4. Immunotherapy; 1.4.1 Immunotherapy Market, By Region; 1.4.1.1 North America Immunotherapy Market, By Country; 1.4.1.2 Europe Immunotherapy Market, By Country; 1.4.1.3 Asia-Pacific Immunotherapy Market, By Country; 1.4.1.4 Rest of World Immunotherapy Market, By Country; 1.5. Radiotherapy; 1.5.1 Radiotherapy Market, By Region; 1.5.1.1 North America Radiotherapy Market, By Country; 1.5.1.2 Europe Radiotherapy Market, By Country; 1.5.1.3 Asia-Pacific Radiotherapy Market, By Country; 1.5.1.4 Rest of World Radiotherapy Market, By Country
2. Global Castrate-resistant Prostate Cancer Market, By Region: 2.1. Overview; 2.2. North America; 2.2.1 North America Castrate-resistant Prostate Cancer Market, By Therapy; 2.2.2 North America Castrate-resistant Prostate Cancer Market, By Country; 2.2.2.1 U.S.; 2.2.2.1.1 U.S. Castrate-resistant Prostate Cancer Market, By Therapy; 2.2.2.2 Canada; 2.2.2.2.1 Canada Castrate-resistant Prostate Cancer Market, By Therapy; 2.3. Europe; 2.3.1 Europe Castrate-resistant Prostate Cancer Market, By Therapy; 2.3.2 Europe Castrate-resistant Prostate Cancer Market, By Country; 2.3.2.1 Germany; 2.3.2.1.1 Germany Castrate-resistant Prostate Cancer Market, By Therapy; 2.3.2.2 U.K.; 2.3.2.2.1 U.K. Castrate-resistant Prostate Cancer Market, By Therapy; 2.3.2.3 France; 2.3.2.3.1 France Castrate-resistant Prostate Cancer Market, By Therapy; 2.3.2.4 Italy; 2.3.2.4.1 Italy Castrate-resistant Prostate Cancer Market, By Therapy; 2.3.2.5 Spain; 2.3.2.5.1 Spain Castrate-resistant Prostate Cancer Market, By Therapy; 2.3.2.6 Rest of Europe; 2.3.2.6.1 Rest of Europe Castrate-resistant Prostate Cancer Market, By Therapy; 2.4. Asia-Pacific; 2.4.1 Asia-Pacific Castrate-resistant Prostate Cancer Market, By Therapy; 2.4.2 Asia-Pacific Castrate-resistant Prostate Cancer Market, By Country; 2.4.2.1 China; 2.4.2.1.1 China Castrate-resistant Prostate Cancer Market, By Therapy; 2.4.2.2 Japan; 2.4.2.2.1 Japan Castrate-resistant Prostate Cancer Market, By Therapy; 2.4.2.3 South Korea; 2.4.2.3.1 South Korea Castrate-resistant Prostate Cancer Market, By Therapy; 2.4.2.4 India; 2.4.2.4.1 India Castrate-resistant Prostate Cancer Market, By Therapy; 2.4.2.5 Singapore; 2.4.2.5.1 Singapore Castrate-resistant Prostate Cancer Market, By Therapy; 2.4.2.6 Rest of Asia; 2.4.2.6.1 Rest of Asia Castrate-resistant Prostate Cancer Market, By Therapy; 2.5. Rest of World; 2.5.1 Rest of World Castrate-resistant Prostate Cancer Market, By Therapy; 2.5.2 Rest of World Castrate-resistant Prostate Cancer Market, By Country; 2.5.2.1 Brazil; 2.5.2.1.1 Brazil Castrate-resistant Prostate Cancer Market, By Therapy; 2.5.2.2 Mexico; 2.5.2.2.1 Mexico Castrate-resistant Prostate Cancer Market, By Therapy; 2.5.2.3 South Africa; 2.5.2.3.1 South Africa Castrate-resistant Prostate Cancer Market, By Therapy; 2.5.2.4 Australia; 2.5.2.4.1 Australia Castrate-resistant Prostate Cancer Market, By Therapy; 2.5.2.5 ROW Countries; 2.5.2.5.1 ROW Countries Castrate-resistant Prostate Cancer Market, By Therapy; ROW Countries Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD LIST OF TABLES; TABLE 1. Global Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 2. Chemotherapy Market Value, By Region, 2022-2031, Million USD; TABLE 3. North America Chemotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 4. Europe Chemotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 5. Asia-Pacific Chemotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 6. Rest of World Chemotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 7. Hormonal Therapy Market Value, By Region, 2022-2031, Million USD; TABLE 8. North America Hormonal Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 9. Europe Hormonal Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 10. Asia-Pacific Hormonal Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 11. Rest of World Hormonal Therapy Market Value, By Country, 2022-2031, Million USD; TABLE 12. Immunotherapy Market Value, By Region, 2022-2031, Million USD; TABLE 13. North America Immunotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 14. Europe Immunotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 15. Asia-Pacific Immunotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 16. Rest of World Immunotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 17. Radiotherapy Market Value, By Region, 2022-2031, Million USD; TABLE 18. North America Radiotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 19. Europe Radiotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 20. Asia-Pacific Radiotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 21. Rest of World Radiotherapy Market Value, By Country, 2022-2031, Million USD; TABLE 22. Global Castrate-resistant Prostate Cancer Market Value, By Region, 2022-2031, Million USD; TABLE 23. North America Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 24. North America Castrate-resistant Prostate Cancer Market Value, By Country, 2022-2031, Million USD; TABLE 25. U.S. Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 26. Canada Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 27. Europe Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 28. Europe Castrate-resistant Prostate Cancer Market Value, By Country, 2022-2031, Million USD; TABLE 29. Germany Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 30. U.K. Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 31. France Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 32. Italy Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 33. Spain Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 34. Rest of Europe Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 35. Asia-Pacific Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 36. Asia-Pacific Castrate-resistant Prostate Cancer Market Value, By Country, 2022-2031, Million USD; TABLE 37. China Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 38. Japan Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 39. South Korea Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 40. India Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 41. Singapore Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 42. Rest of Asia Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 43. Rest of World Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 44. Rest of World Castrate-resistant Prostate Cancer Market Value, By Country, 2022-2031, Million USD; TABLE 45. Brazil Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 46. Mexico Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 47. South Africa Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 48. Australia Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; TABLE 49. ROW Countries Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD; ROW Countries Castrate-resistant Prostate Cancer Market Value, By Therapy, 2022-2031, Million USD